• News

    News

GLIOMARK 1 Phase II clinical study currently recruiting patients

GLIOMARK1 Phase II clinical study (EudraCT No: 2015-005573-21), as part clinical development of GLIOMARK project, is currently recruiting patients. The study is entitled: "Exploratory phase II study in patients after treatment of high grade brain tumors to assess the technical performance of Tc-99m tetrofosmin for differentiation of recurrence versus radiation necrosis"


Contact us

Address:20, Delfon Street
151 25 Marousi,
Athens-Greece
Phone:+30-210-6622386
Fax:+30-210-6622332
Email:This email address is being protected from spambots. You need JavaScript enabled to view it.